Bispecific antibodies: raising new horizons for RRMM?
After participating in this webinar, viewers should be able to:
- Discuss the latest data relating to the use of bispecifics in the management of patients with RRMM
- María Victoria Mateos (Spain)
- Niels van de Donk (Netherlands)
- Ajai Chari (USA)